Purpan University Hospital
Toulouse, 31059, France
Location status: Recruiting
Location contact
Françoise Auriol, PhD
CONTACT
5 67 77 10 95 ext. 0033
Thomas Edouard, MD, PhD
CONTACT
5 34 55 85 55 ext. 0033
NCT Number: NCT04970459
The present study will establish a collection of biological samples from Marfan patients or with associated diseases to be used for research purposes only, with due respect for confidentiality.
Interested in participating?
Request Info3 year–99 year
All sexes
Observational
Toulouse, 31059, France
Location status: Recruiting
Françoise Auriol, PhD
CONTACT
5 67 77 10 95 ext. 0033
Thomas Edouard, MD, PhD
CONTACT
5 34 55 85 55 ext. 0033
Marfan syndrome is an autosomal dominant disease (incidence 1/5000) characterized by ocular, cardiac and skeletal abnormalities. More recently, a decrease in fat and muscle mass has been demonstrated, associated with a decrease in exercise endurance, causing a significant deterioration in the quality of life. Little is known about the pathophysiology of these symptoms. Patients with Marfan syndrome or related diseases are followed at the children's hospital as part of the Rare Diseases Reference Centre (CRMR) for Marfan syndrome at the Toulouse University Hospital. During regular check-up visits, an extra sample of blood and urine will be collected and stored for research utilisation with the patient's consent. The ultimate objective of this collection is to provide available biological resources to facilitate the development of subsequent studies aimed at better characterizing the multisystemic disorders in Marfan syndrome, to understand the pathophysiology of the disease, and to identify biological factors that predict the severity and progression of the disease. The possibility of having systematically collected biological resources will make it possible to answer certain questions more quickly depending on the progress of research.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
extra samples of blood and urine will be collected and stored for research utilisation
Time frame: Day 0
extra sample of blood and urine will be collected
Time frame: during the intervention/procedure/surgery
extra sample of blood and urine will be collected
Contact information is provided by the study sponsor or research team.
Françoise Auriol, PhD
CONTACT
5 67 77 10 95 ext. 0033
Thomas Edouard, MD, PhD
CONTACT
5 34 55 85 55 ext. 0033
University Hospital, Toulouse
Other
Constitution of a Biological Collection to Study the Pathophysiology in Marfan Syndrome and Related Syndromes and to Identify Predictive Factors of Disease Progression
Acronym: MARFANS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07672210
Abnormalities, Multiple, Acute Aortic Syndrome
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT06546137
Abnormalities, Multiple, Aneurysm
Rio Branco, Acre, Brazil
View Trial DetailsNCT05838235
Abnormalities, Multiple, Bone Diseases
Toulouse, France
View Trial DetailsNCT02050113
Abnormalities, Multiple, Acute Aortic Syndrome
Worcester, Massachusetts, United States
View Trial Details